← Back to Search
Neuroimaging for Migraine
Phoenix, AZ
N/A
Waitlist Available
Led By Catherine Chong, PhD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Female only.
Ages 20-45 years.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
No Placebo-Only Group
Summary
This trial is investigating whether WMH are more common in women with migraines, and if so, what characteristics they have.
See full description
Who is the study for?
This study is specifically for women aged 20-45 who have white matter hyperintensities (WMH) on their brain MRI, which can be related to conditions like migraines or small vessel disease.Check my eligibility
What is being tested?
The trial is focused on using brain neuroimaging techniques to investigate the presence and characteristics of WMH in women suffering from migraines.See study design
What are the potential side effects?
Since this trial involves non-invasive brain imaging, there are minimal side effects. Participants may experience discomfort from lying still during the MRI procedure.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am female.
show original
Select...
I am between 20 and 45 years old.
show original
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
WMH imaging disease parameters
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Group I: Small vessel ischemic (SVI) disease cohortExperimental Treatment1 Intervention
Women diagnosed with SVI disease and presence of white matter hyperintensities (WMH) on clinical magnetic resonance imaging (MRI) will have brain neuroimaging.
Group II: Multiple sclerosis (MS) cohortExperimental Treatment1 Intervention
Women diagnosed with MS and presence of white matter hyperintensities (WMH) on clinical magnetic resonance imaging (MRI) will have brain neuroimaging.
Group III: Migraine cohortExperimental Treatment1 Intervention
Women with migraine and presence of white matter hyperintensities (WMH) on clinical magnetic resonance imaging (MRI) will have brain neuroimaging.
Find a Location
Closest Location:Mayo Clinic in Arizona· Phoenix, AZ· 1487 miles
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,415 Previous Clinical Trials
3,209,184 Total Patients Enrolled
11 Trials studying Migraine
82,026 Patients Enrolled for Migraine
Catherine Chong, PhDPrincipal InvestigatorMayo Clinic
1 Previous Clinical Trials
260 Total Patients Enrolled